Literature DB >> 11181734

Immunohistochemical localization of laminin and fibronectin isoforms in human placental villi.

M Korhonen1, I Virtanen.   

Abstract

We studied the localization of laminin alpha1, alpha2, alpha3, alpha5, beta1, beta2, and gamma1 chains and extradomain A- (EDA), EDB-, and oncofetal fibronectin by immunohistochemistry in human placental villi during placental development. The laminin alpha2, alpha5, beta1, beta2, and gamma1 chains were detected in the trophoblastic basement membrane (BM) at all stages of gestation, suggesting the presence of laminin-2, -4, -10, and -11 trimers. The laminin alpha1 chain was selectively found at sites where the villous BM was in contact with proliferating cells in trophoblastic islands or columns. EDA-Fn, but not other Fn isoforms, was found in the trophoblastic BM during the first trimester. The laminin alpha2, beta1, beta2, and gamma1 chains were detected in the villous stroma and capillaries throughout placental development, while the laminin alpha5 chain emerged distinctly during development. Extensive EDA-Fn immunoreactivity was found in first-trimester villous stroma, but distinctly fewer Fn isoforms were seen in the villous stroma during the later stages of gestation. Our results also suggest that, during the formation of new villi, laminins are not found in trophoblastic sprouts before the ingrowth of the villous mesenchyme. Rather, laminins may be deposited at the villous epithelial-mesenchymal interface. Furthermore, the results show that distinct changes occur in the localization of various laminin and Fn isoforms during the maturation of villous trophoblastic and capillary BMs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181734     DOI: 10.1177/002215540104900305

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  7 in total

1.  D2-40/podoplanin expression in the human placenta.

Authors:  Y Wang; J Sun; Y Gu; S Zhao; L J Groome; J S Alexander
Journal:  Placenta       Date:  2010-11-20       Impact factor: 3.481

2.  Maternal alloimmune IgG causes anti-glomerular basement membrane disease in perinatal transgenic mice that express human laminin α5.

Authors:  Dale R Abrahamson; Brooke M Steenhard; Larysa Stroganova; Adrian Zelenchuk; Patricia L St John; Margaret G Petroff; Manuel Patarroyo; Dorin Bogdan Borza
Journal:  Kidney Int       Date:  2019-07-10       Impact factor: 10.612

3.  Bone marrow-derived mesenchymal stromal cells differ in their attachment to fibronectin-derived peptides from term placenta-derived mesenchymal stromal cells.

Authors:  Jan K Maerz; Lorenzo P Roncoroni; David Goldeck; Tanja Abruzzese; Hubert Kalbacher; Bernd Rolauffs; Peter DeZwart; Kay Nieselt; Melanie L Hart; Gerd Klein; Wilhelm K Aicher
Journal:  Stem Cell Res Ther       Date:  2016-02-11       Impact factor: 6.832

4.  High temperature requirement A1 and fibronectin: two possible players in placental tissue remodelling.

Authors:  G Tossetta; C Avellini; C Licini; S R Giannubilo; M Castellucci; D Marzioni
Journal:  Eur J Histochem       Date:  2016-11-21       Impact factor: 3.188

5.  miRNAs and Their Gene Targets-A Clue to Differentiate Pregnancies with Small for Gestational Age Newborns, Intrauterine Growth Restriction, and Preeclampsia.

Authors:  Angelika V Timofeeva; Ivan S Fedorov; Alexander G Brzhozovskiy; Anna E Bugrova; Vitaliy V Chagovets; Maria V Volochaeva; Natalia L Starodubtseva; Vladimir E Frankevich; Evgeny N Nikolaev; Roman G Shmakov; Gennady T Sukhikh
Journal:  Diagnostics (Basel)       Date:  2021-04-20

Review 6.  Placental Tissues as Biomaterials in Regenerative Medicine.

Authors:  Annelise Roy; Morgan Mantay; Courtney Brannan; Sarah Griffiths
Journal:  Biomed Res Int       Date:  2022-04-21       Impact factor: 3.246

7.  Functional consequences of cell type-restricted expression of laminin α5 in mouse placental labyrinth and kidney glomerular capillaries.

Authors:  Sung Tae Kim; Tracy L Adair-Kirk; Robert M Senior; Jeffrey H Miner
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.